Trial · NCT02570321
Results by group52
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 52
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Microbiological Cure on Repeat Culture | Bacterial Ulcer Control | Culture negative | 5 | Participants | |
| Microbiological Cure on Repeat Culture | Bacterial Ulcer Cross-linking | Culture negative | 5 | Participants | |
| Microbiological Cure on Repeat Culture | Fungal Ulcer Control With Natamycin | Culture negative | 17 | Participants | |
| Microbiological Cure on Repeat Culture | Fungal Ulcer Cross-linking Plus Natamycin | Culture negative | 14 | Participants | |
| Microbiological Cure on Repeat Culture | Fungal Ulcer Control With Amphotericin | Culture negative | 15 | Participants | |
| Microbiological Cure on Repeat Culture | Fungal Ulcer Cross-linking Plus Amphotericin | Culture negative | 13 | Participants | |
| Microbiological Cure on Repeat Culture | Bacterial Ulcer Control | Culture positive | 14 | Participants | |
| Microbiological Cure on Repeat Culture | Bacterial Ulcer Cross-linking | Culture positive | 11 | Participants | |
| Microbiological Cure on Repeat Culture | Fungal Ulcer Control With Natamycin | Culture positive | 9 | Participants | |
| Microbiological Cure on Repeat Culture | Fungal Ulcer Cross-linking Plus Natamycin | Culture positive | 12 | Participants | |
| Microbiological Cure on Repeat Culture | Fungal Ulcer Control With Amphotericin | Culture positive | 12 | Participants | |
| Microbiological Cure on Repeat Culture | Fungal Ulcer Cross-linking Plus Amphotericin | Culture positive | 13 | Participants | |
| Best Spectacle-corrected Visual Acuity | Bacterial Ulcer Control | 0.82 | Inter-Quartile Range 0.62 to 1.4 | logMar | |
| Best Spectacle-corrected Visual Acuity | Bacterial Ulcer Cross-linking | 1.32 | Inter-Quartile Range 0.43 to 1.75 | logMar | |
| Best Spectacle-corrected Visual Acuity | Fungal Ulcer Control With Natamycin | 0.43 | Inter-Quartile Range 0.1 to 0.72 | logMar | |
| Best Spectacle-corrected Visual Acuity | Fungal Ulcer Cross-linking Plus Natamycin | 1 | Inter-Quartile Range 0.3 to 1.8 | logMar | |
| Best Spectacle-corrected Visual Acuity | Fungal Ulcer Control With Amphotericin | 0.48 | Inter-Quartile Range 0.2 to 1.7 | logMar | |
| Best Spectacle-corrected Visual Acuity | Fungal Ulcer Cross-linking Plus Amphotericin | 0.8 | Inter-Quartile Range 0.5 to 1.24 | logMar | |
| Scar Size | Bacterial Ulcer Control | 3.5 | 95% Confidence Interval 2.7 to 4.0 | mm | |
| Scar Size | Bacterial Ulcer Cross-linking | 3.0 | 95% Confidence Interval 2.24 to 4.0 | mm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02570321/results